• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRMT5 对于 eIF4E 介导的 5' 帽依赖翻译是必不可少的。

PRMT5 is essential for the eIF4E-mediated 5'-cap dependent translation.

机构信息

Department of Biomedical Chemistry, College of Biomedical & Health Science, Konkuk University, Chungju 380-701, Chungbuk, Republic of Korea.

Department of Food Bioscience, College of Biomedical & Health Science, Konkuk University, Chungju 380-701, Chungbuk, Republic of Korea.

出版信息

Biochem Biophys Res Commun. 2014 Oct 3;452(4):1016-21. doi: 10.1016/j.bbrc.2014.09.033. Epub 2014 Sep 16.

DOI:10.1016/j.bbrc.2014.09.033
PMID:25234597
Abstract

It is becoming clear that PRMT5 plays essential roles in cell cycle progression, survival, and responses to external stresses. However, the precise mechanisms underlying such roles of PRMT5 have not been clearly understood. Previously, we have demonstrated that PRMT5 participates in cellular adaptation to hypoxia by ensuring 5'-cap dependent translation of HIF-1α. Given that c-Myc and cyclin D1 expressions are also tightly regulated in 5'-cap dependent manner, we here tested the possibility that PRMT5 promotes cell proliferation by increasing de novo syntheses of the oncoproteins. c-Myc and cyclin D1 were found to be noticeably downregulated by PRMT5 knock-down. A RNA immunoprecipitation analysis, which can identify RNA-protein interactions, showed that PRMT5 is required for the interaction among eIF4E and 5'-UTRs of HIF-1α, c-Myc and cyclin D1 mRNAs. In addition, PRMT5 knock-down inhibited cell proliferation by inducing cell cycle arrest at the G1 phase. More importantly, ectopic expression of eIF4E significantly rescued the cell cycle progression and cell proliferation even in PRMT5-deficeint condition. Based on these results, we propose that PRMT5 determines cell fate by regulating 5'-cap dependent translation of proteins essential for proliferation and survival.

摘要

越来越多的证据表明 PRMT5 在细胞周期进程、存活和对外界应激的反应中发挥着重要作用。然而,PRMT5 发挥这些作用的确切机制尚未被清楚地理解。先前,我们已经证明 PRMT5 通过确保 HIF-1α 的 5'-帽依赖翻译来参与细胞对缺氧的适应。鉴于 c-Myc 和细胞周期蛋白 D1 的表达也受到严格的 5'-帽依赖调控,我们在这里测试了 PRMT5 通过增加新合成的癌蛋白来促进细胞增殖的可能性。PRMT5 敲低明显下调了 c-Myc 和 cyclin D1 的表达。一种可以鉴定 RNA-蛋白相互作用的 RNA 免疫沉淀分析表明,PRMT5 是 eIF4E 与 HIF-1α、c-Myc 和 cyclin D1 mRNA 的 5'-UTR 之间相互作用所必需的。此外,PRMT5 敲低通过诱导细胞周期停滞在 G1 期来抑制细胞增殖。更重要的是,即使在 PRMT5 缺陷的情况下,eIF4E 的异位表达也显著挽救了细胞周期进程和细胞增殖。基于这些结果,我们提出 PRMT5 通过调节对增殖和存活至关重要的蛋白质的 5'-帽依赖翻译来决定细胞命运。

相似文献

1
PRMT5 is essential for the eIF4E-mediated 5'-cap dependent translation.PRMT5 对于 eIF4E 介导的 5' 帽依赖翻译是必不可少的。
Biochem Biophys Res Commun. 2014 Oct 3;452(4):1016-21. doi: 10.1016/j.bbrc.2014.09.033. Epub 2014 Sep 16.
2
Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.靶向蛋白质精氨酸甲基转移酶5通过降低真核翻译起始因子4E(eIF4E)和纤维母细胞生长因子受体3(FGFR3)的精氨酸甲基化来抑制结直肠癌的生长。
Oncotarget. 2015 Sep 8;6(26):22799-811. doi: 10.18632/oncotarget.4332.
3
Protein arginine methyltransferase 5 is an essential component of the hypoxia-inducible factor 1 signaling pathway.蛋白质精氨酸甲基转移酶 5 是缺氧诱导因子 1 信号通路的必需组成部分。
Biochem Biophys Res Commun. 2012 Feb 10;418(2):254-9. doi: 10.1016/j.bbrc.2012.01.006. Epub 2012 Jan 9.
4
Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G1 cyclins/cyclin-dependent kinases and the phosphoinositide 3-kinase/AKT signaling cascade.精氨酸甲基转移酶 5 是一种潜在的癌蛋白,可上调 G1 周期蛋白/细胞周期依赖性激酶和磷脂酰肌醇 3-激酶/AKT 信号级联。
Cancer Sci. 2012 Sep;103(9):1640-50. doi: 10.1111/j.1349-7006.2012.02367.x. Epub 2012 Aug 8.
5
PRMT5 is required for cell-cycle progression and p53 tumor suppressor function.细胞周期进程和p53肿瘤抑制功能需要PRMT5。
Nucleic Acids Res. 2009 Aug;37(15):4965-76. doi: 10.1093/nar/gkp516. Epub 2009 Jun 15.
6
Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.精氨酸甲基转移酶抑制剂1通过下调真核翻译起始因子4E(eIF4E)并靶向蛋白精氨酸甲基转移酶5(PRMT5)来抑制胃癌。
Toxicol Appl Pharmacol. 2017 Dec 1;336:1-7. doi: 10.1016/j.taap.2017.10.002. Epub 2017 Oct 4.
7
Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation.利巴韦林通过下调 PRMT5 表达和 H3R8me2s 和 H4R3me2s 积累抑制结直肠癌生长。
Toxicol Appl Pharmacol. 2021 Mar 15;415:115450. doi: 10.1016/j.taap.2021.115450. Epub 2021 Feb 9.
8
eIF4E is a central node of an RNA regulon that governs cellular proliferation.真核生物翻译起始因子4E(eIF4E)是一个RNA调节子的核心节点,该调节子控制细胞增殖。
J Cell Biol. 2006 Nov 6;175(3):415-26. doi: 10.1083/jcb.200607020. Epub 2006 Oct 30.
9
PRMT5 Promotes Cyclin E1 and Cell Cycle Progression in CD4 Th1 Cells and Correlates With EAE Severity.PRMT5促进CD4 Th1细胞中细胞周期蛋白E1和细胞周期进程,并与实验性自身免疫性脑脊髓炎严重程度相关。
Front Immunol. 2021 Jun 8;12:695947. doi: 10.3389/fimmu.2021.695947. eCollection 2021.
10
PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.PRMT5是由多种致癌驱动因素引发的淋巴瘤发生所必需的。
Cancer Discov. 2015 Mar;5(3):288-303. doi: 10.1158/2159-8290.CD-14-0625. Epub 2015 Jan 12.

引用本文的文献

1
The PRMT5/WDR77 complex restricts hepatitis E virus replication.PRMT5/WDR77 复合物限制戊型肝炎病毒复制。
PLoS Pathog. 2023 Jun 5;19(6):e1011434. doi: 10.1371/journal.ppat.1011434. eCollection 2023 Jun.
2
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation.PRMT5 失调促进慢性淋巴细胞白血病进展并增加 Richter 转化的高危风险。
Nat Commun. 2023 Jan 6;14(1):97. doi: 10.1038/s41467-022-35778-1.
3
Downregulation of PRMT5 by AMI-1 enhances therapeutic efficacy of compound kushen injection in lung carcinoma in vitro and in vivo.
AMI-1介导的PRMT5下调增强了复方苦参注射液对肺癌的体内外治疗效果。
Mol Cell Biochem. 2023 May;478(5):1031-1044. doi: 10.1007/s11010-022-04577-z. Epub 2022 Oct 10.
4
TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma.TP53 突变和 RNA 结合蛋白 MUSASHI-2 驱动 B 细胞淋巴瘤对 PRMT5 靶向治疗的耐药性。
Nat Commun. 2022 Sep 27;13(1):5676. doi: 10.1038/s41467-022-33137-8.
5
PRMT5 Interacting Partners and Substrates in Oligodendrocyte Lineage Cells.少突胶质细胞系细胞中PRMT5的相互作用蛋白和底物
Front Cell Neurosci. 2022 Mar 17;16:820226. doi: 10.3389/fncel.2022.820226. eCollection 2022.
6
Pre-mRNA processing factor 19 functions in DNA damage repair and radioresistance by modulating cyclin D1 in hepatocellular carcinoma.前体mRNA加工因子19通过调节肝细胞癌中的细胞周期蛋白D1在DNA损伤修复和放射抗性中发挥作用。
Mol Ther Nucleic Acids. 2021 Dec 9;27:390-403. doi: 10.1016/j.omtn.2021.12.002. eCollection 2022 Mar 8.
7
Protein Arginine Methyltransferase 5 as a Therapeutic Target for Mutated Colorectal Cancer.蛋白质精氨酸甲基转移酶5作为突变型结直肠癌的治疗靶点
Cancers (Basel). 2020 Jul 28;12(8):2091. doi: 10.3390/cancers12082091.
8
PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair Genes.PRMT5与pICln协同作用,作为DNA双链断裂修复基因的主要表观遗传激活因子发挥作用。
iScience. 2020 Jan 24;23(1):100750. doi: 10.1016/j.isci.2019.100750. Epub 2019 Nov 29.
9
NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms.NF-κB/mTOR/MYC 轴通过转录和非转录机制驱动 T 细胞激活后 PRMT5 蛋白的诱导。
Front Immunol. 2019 Mar 19;10:524. doi: 10.3389/fimmu.2019.00524. eCollection 2019.
10
Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer.蛋白质精氨酸甲基转移酶5(PRMT5)在癌症中的失调。
Oncotarget. 2018 Nov 30;9(94):36705-36718. doi: 10.18632/oncotarget.26404.